Results 151 to 160 of about 9,121 (212)

Mechanisms of Therapeutic Resistance and Recent Advances in Glioblastoma Treatment. [PDF]

Immunol Cell Biol
Achari E, Ahmady-Nield F, Sharma A, Schmidt-Wolf IGH, Maciaczyk J, Luwor RB, Achuthan AA.   +6 more
europepmc   +1 more source

Heterodimerization with signaling-inert TLR8b converts TLR8a from proviral to antiviral sensor in Ctenopharyngodon idella. [PDF]

Cell Commun Signal
Zhang J, Lv M, Wang S, Xu Y, Wang P, Tang B, Liao Z, Jiang R, Chen G, Xiong N, Yang C, Liu J, Su J.   +12 more
europepmc   +1 more source

Disease-free survival as a surrogate outcome for localized kidney cancer-A systematic review and meta-analysis. [PDF]

Cancer
Martinez C, Chen D, Leong R, Lum N, Xiao K, Almasri L, Kollmannsberger CK, Raman S.   +7 more
europepmc   +1 more source

Dual targeting of solid tumors using cytokine-induced killer cells modified with a CAR anti-tenascin C and a secretable EGFRxCD3 bispecific antibody. [PDF]

Cancer Immunol Immunother
Zaninelli S, Cattaneo I, Valgardsdottir R, Frapolli R, Bello E, Meroni M, Gianatti A, Panna S, Rizzo P, Tomasoni S, D'Incalci M, Introna M, Golay J, Rambaldi A.   +13 more
europepmc   +1 more source

DEAD-box helicase gcDDX56 disrupts IRF3 nuclear import complex and promotes nuclear IRF3 degradation for enhancing GCRV replication. [PDF]

J Virol
Xiao LL, Chen Y, Zhang J, Xiao J, Feng H, Chang MX.   +5 more
europepmc   +1 more source

Evaluating patient-reported outcomes in randomized controlled trials of targeted therapy and/or immunotherapy for liver cancer: a scoping review. [PDF]

Front Oncol
Ren L, Liu Y, Li S, Yue S, Su C, Wang J, Zhang Y.   +6 more
europepmc   +1 more source

The global clinical trial landscape of lung cancer cellular therapy current status trends and scientific challenges. [PDF]

Discov Oncol
Song C, Lu DS, Zhao CY, Xu ZY, Peng HJ, Li XL, Zeng HY, Li JH, Guo JJ, Yang N.   +9 more
europepmc   +1 more source

Reprogramming dendritic cells to overcome tumor-mediated immune suppression. [PDF]

Front Immunol
Malik JA.
europepmc   +1 more source

Advances in adoptive cell therapy for ovarian cancer. [PDF]

Front Immunol
Zhao N, An Y, Guo S, Xu Z, Shi H, Zhang Z.   +5 more
europepmc   +1 more source

Case Report: Three cases with allogeneic CIK therapy against solid tumors. [PDF]

Front Immunol
Li Y, Wang X, Yao L, Lin J, Wang R, Zheng Q.   +5 more
europepmc   +1 more source